Cardinal Health Stock Symbol CAH Explained

The CAH stock symbol is associated with Cardinal Health, a global company that provides healthcare products and services.

Cardinal Health was founded in 1971.

As a major player in the healthcare industry, Cardinal Health has a diverse portfolio of products and services, including medical and surgical products, pharmaceuticals, and medical technologies.

The company's stock is listed on the New York Stock Exchange (NYSE), where it trades under the CAH symbol.

If this caught your attention, see: Free Basic Healthcare and Inscrease of Taxes

Cardinal Health's revenue in 2024 was $226.83 billion, a 10.66% increase from the previous year. This growth is a testament to the company's strong financial performance.

The company's earnings in 2024 were $852.00 million, a significant increase of 158.18% compared to the previous year. This surge in earnings is a result of Cardinal Health's effective management and strategic decisions.

In 2025, Cardinal Health's revenue is estimated to reach $220,128 million, with an average estimate of $220,128 million from 12 analysts. This estimate represents a significant growth from the previous year's revenue.

The company's dividend yield in 2025 is estimated to be 1.70%, with a dividend of $2.06. This indicates that investors can expect a relatively stable return on their investment.

Cardinal Health's earnings per share (EPS) in 2025 is estimated to be $7.84, with an average estimate of $7.84 from 15 analysts. This represents a significant increase from the previous year's EPS.

Here is a summary of Cardinal Health's estimated financial performance for 2025:

These estimates suggest that Cardinal Health is poised for continued growth and success in 2025.

Cardinal Health's Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. This dividend is a significant part of the company's history of rewarding shareholders.

The company has been paying dividends since 1999, with the first dividend being $0.07 per share. Over the years, the dividend has increased, and in 2024, the company announced a quarterly dividend of $2.01.

Here's a breakdown of the company's dividend history:

Cardinal Health's stock has an average rating of "Buy" from 13 analysts, with a 12-month stock price forecast of $132.46, representing an 8.96% increase from the latest price.

The average earnings estimate for the current year is $7.84, with a growth rate estimated at -4.40% year over year. Analysts are also predicting a revenue of $220,128 in 2025, with an average estimate of $238,915 for the next year.

Here's a breakdown of the average earnings estimate for the current year:

The conference featured company participants Matt Sims, Vice President of Investor Relations, and Aaron Alt, Chief Financial Officer.

Cardinal Health, Inc. (CAH) has received a positive analyst forecast, with an average rating of "Buy" from 13 analysts, predicting a 12-month stock price forecast of $132.46, representing an 8.96% increase from the latest price.

Discover more: Omega Healthcare Investors Stock Price

Analysts are overwhelmingly optimistic about CAH stock, with an average rating of "Buy" from 13 analysts. The 12-month stock price forecast is $132.46, a 8.96% increase from the latest price.

The average earnings estimate for CAH is $1.74, with a high estimate of $1.86 and a low estimate of $1.46, based on 8 estimates. The growth rate estimate (year over year) is -4.40%.

Analysts have consistently increased their earnings estimates for CAH, with the average estimate for the current quarter ending 03/31/25 at $2.192 USD, up from $1.763 USD in the previous quarter.

Here are the earnings estimates for CAH over the past few quarters:

These estimates suggest a strong growth trajectory for CAH, with analysts expecting the company to continue to perform well in the coming quarters.

Cardinal Health stock shares hit a new all-time intraday high, reaching a price of $122.75. This remarkable milestone was achieved despite the company taking a financial hit from various factors.

The stock's past performance has been quite impressive, with a 52-week high of $126.23 and a year range of $92 to $125. This indicates a significant increase in the stock's value over the past year.

Cardinal Health's market capitalization is substantial, standing at $29,421,156,000. This is a testament to the company's size and influence in the healthcare industry.

Here's a summary of the stock's recent performance:

The Barchart Technical Opinion rating is a 80% Buy, indicating a strong buying signal. This suggests that the market is currently in a favorable position for investors.

Cardinal Health's management team is led by Jason M. Hollar, the Chief Executive Officer & Director. He's been at the helm since at least August 18, 2024.

Stephen M. Mason is also a key executive, serving as Chief Executive Officer-Medical Segment. Ola M. Snow is the Chief Human Resources Officer, overseeing the company's HR operations.

Here's a breakdown of the company's insider activity:

Note that this is not an exhaustive list, but it gives you an idea of the insider activity at Cardinal Health.

Cardinal Health has made significant moves to expand its portfolio with two strategic additions.

The company acquired a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy.

This acquisition is a key step in Cardinal Health's plans to grow its business through strategic partnerships and investments.

Cardinal Health has made a significant investment in GI Alliance, acquiring a majority stake in the company.

Cardinal Health Inc has seen some notable performance metrics in recent times. The company's diluted earnings per share (EPS) for the trailing 12 months (TTM) stands at 5.2.

Revenue growth year-over-year (YOY) has been a concern, with a decline of 4.3%.

The company's earnings growth YOY has been impressive, with a staggering 4,813% increase.

Profit margins have been relatively stable, with a profit margin of 0.57%.

Here's a quick rundown of Cardinal Health Inc's key performance metrics:

The management team at Cardinal Health is comprised of experienced professionals who oversee various aspects of the company.

Mary C. Scherer serves as the Chief Accounting Officer & Senior Vice President, responsible for managing the company's financial activities.

Jessica L. Mayer is the Chief Compliance & Legal Officer, ensuring that the company adheres to all relevant laws and regulations.

Jason M. Hollar holds the position of Chief Executive Officer & Director, overseeing the overall strategy and direction of the company.

Stephen M. Mason and Debbie Weitzman serve as Chief Executive Officers for the Medical Segment and Pharmaceutical Segment, respectively.

Aaron E. Alt is the Chief Financial Officer, responsible for managing the company's financial health.

Ola M. Snow serves as the Chief Human Resources Officer, overseeing the company's human resources functions.

Michelle D. Greene is the Chief Information Officer & Executive VP, responsible for managing the company's information technology.

Craig Cowman is the EVP-Strategic Sourcing & Manufacturer Services, focusing on the company's sourcing and manufacturing activities.

The independent directors of the company include Akhil Johri, Christine Ann Mundkur, David C. Evans, Michelle M. Brennan, Nancy Killefer, Patricia A. Hemingway Hall, Robert W. Azelby, Sheri H. Edison, and Gregory B. Kenny, who serves as the Independent Non-Executive Chairman.

Key leadership roles at Cardinal Health also include Patrick Pope, who serves as Secretary, Executive VP & General Counsel, and Lisa Capodici and Matt Sims, who are both Vice Presidents of Investor Relations.

Worth a look: Medical Information Bureau Mib

Cardinal Health has seen significant insider activity in recent months. Insider trading can be a good indicator of market trends and company performance.

Mayer Jessica L sold 16,573 shares on August 20, 2024, at a price of $109.39 per share.

In the past few months, several executives have sold shares of Cardinal Health stock. Snow Ola M sold 34,647 shares on August 18, 2024, at a price of $109.00 per share.

Some executives have also bought shares of Cardinal Health stock. Mason Stephen M bought 46,598 shares on August 18, 2024, at a price of $109.21 per share.

Here are some key insider transactions:

The executives who sold shares have still retained a significant amount of stock in Cardinal Health.